
PharmaBlock Sciences Nanjing Inc
SZSE:300725

Intrinsic Value
The intrinsic value of one
PharmaBlock Sciences Nanjing Inc
stock under the Base Case scenario is
39.98
CNY.
Compared to the current market price of 32.55 CNY,
PharmaBlock Sciences Nanjing Inc
is
Undervalued by 19%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
PharmaBlock Sciences Nanjing Inc
Fundamental Analysis


Revenue & Expenses Breakdown
PharmaBlock Sciences Nanjing Inc
Balance Sheet Decomposition
PharmaBlock Sciences Nanjing Inc
Current Assets | 2.7B |
Cash & Short-Term Investments | 1.4B |
Receivables | 493.6m |
Other Current Assets | 849.1m |
Non-Current Assets | 2.2B |
Long-Term Investments | 19.9m |
PP&E | 1.7B |
Intangibles | 463.7m |
Other Non-Current Assets | 50.6m |
Free Cash Flow Analysis
PharmaBlock Sciences Nanjing Inc
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
PharmaBlock Sciences Nanjing Inc
Revenue
|
1.8B
CNY
|
Cost of Revenue
|
-1.2B
CNY
|
Gross Profit
|
597m
CNY
|
Operating Expenses
|
-371.5m
CNY
|
Operating Income
|
225.5m
CNY
|
Other Expenses
|
-19.7m
CNY
|
Net Income
|
205.8m
CNY
|
Profitability Score
Profitability Due Diligence
PharmaBlock Sciences Nanjing Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Score
PharmaBlock Sciences Nanjing Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
PharmaBlock Sciences Nanjing Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Score
PharmaBlock Sciences Nanjing Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
PharmaBlock Sciences Nanjing Inc
According to Wall Street analysts, the average 1-year price target for
PharmaBlock Sciences Nanjing Inc
is 40.8 CNY
with a low forecast of 40.4 CNY and a high forecast of 42 CNY.
Dividends
Current shareholder yield for PharmaBlock Sciences Nanjing Inc is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PharmaBlock Sciences Nanjing Inc
stock under the Base Case scenario is
39.98
CNY.
Compared to the current market price of 32.55 CNY,
PharmaBlock Sciences Nanjing Inc
is
Undervalued by 19%.